اپریسون (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "اپریسون" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

3web.archive.org

1^st place

1^st place

2^nd place

2^nd place

low place

low place

1semanticscholar.org

11^th place

52^nd place

1curehunter.com

low place

low place

1europeanreview.org

low place

low place

1clinicaltrials.gov

5,225^th place

5,710^th place

low place

low place

clinicaltrials.gov

ClinicalTrials.gov NCT00327730 Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain

com.bd

squarepharma.com.bd

"Myonil®" (PDF). Archived from the original (PDF) on 2009-02-06. Retrieved 2008-09-01.
"Myonil®" (PDF). Archived from the original (PDF) on 2010-11-28. Retrieved 2010-06-12.

curehunter.com

"eperisone Summary Report - CureHunter". www.curehunter.com.

doi.org

Yang SI, Park HY, Lee SH, et al. (July 2004). "Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone". Pharmacology. 71 (3): 150–6. doi:10.1159/000077449. PMID 15161997. S2CID 24474033.
Bose K (1999). "The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial". Methods Find Exp Clin Pharmacol. 21 (3): 209–13. doi:10.1358/mf.1999.21.3.534831. PMID 10389124.

europeanreview.org

"Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study". europeanreview.org. 17 October 2012.

jsaweb.jp

jja.jsaweb.jp

Ueno T, Kawana S (July 2007). "[A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema]". Arerugi (به ژاپنی). 56 (7): 709–13. PMID 17671415. Archived from the original on 2014-12-19. Retrieved 2008-09-28.

nih.gov

pubmed.ncbi.nlm.nih.gov

Yang SI, Park HY, Lee SH, et al. (July 2004). "Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone". Pharmacology. 71 (3): 150–6. doi:10.1159/000077449. PMID 15161997. S2CID 24474033.
Bose K (1999). "The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial". Methods Find Exp Clin Pharmacol. 21 (3): 209–13. doi:10.1358/mf.1999.21.3.534831. PMID 10389124.
Ueno T, Kawana S (July 2007). "[A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema]". Arerugi (به ژاپنی). 56 (7): 709–13. PMID 17671415. Archived from the original on 2014-12-19. Retrieved 2008-09-28.

semanticscholar.org

api.semanticscholar.org

Yang SI, Park HY, Lee SH, et al. (July 2004). "Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone". Pharmacology. 71 (3): 150–6. doi:10.1159/000077449. PMID 15161997. S2CID 24474033.

web.archive.org

"Myonil®" (PDF). Archived from the original (PDF) on 2009-02-06. Retrieved 2008-09-01.
"Myonil®" (PDF). Archived from the original (PDF) on 2010-11-28. Retrieved 2010-06-12.
Ueno T, Kawana S (July 2007). "[A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema]". Arerugi (به ژاپنی). 56 (7): 709–13. PMID 17671415. Archived from the original on 2014-12-19. Retrieved 2008-09-28.